GLP-1 (glucagon-like peptide) medications, such as Ozempic and Wegovy, have seen a surge in popularity over the past few ...
As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...
the Big Pharma name-brand versions that insurance usually won’t cover — if they can find it, that is. Simply put, tirzepatide will become unaffordable overnight for many who rely on it. GLP-1 ...
The choice to cover GLP-1s specifically for weight loss remains an evaluation based on the plan’s objectives and budgets. However, it’s critical to consider these potential implications ...
Axios Vitals on MSN29d
Insurers push back on Medicare and Medicaid coverage for GLP-1sMedicare currently only covers GLP-1s for diabetes and heart disease ... The intrigue: Employers and insurers are often on ...
Between 2023 and 2024, employer coverage of GLP-1s increased by 8%. Although some employers cover GLP-1 medications only for diabetes treatment, a growing number are reconsidering this policy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback